Molecular Biology of Cancer: From Biomarkers to Targeted Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 167
Special Issue Editor
Interests: cancer biomarkers; immunohistochemistry; cancer pathogenesis; molecular biology of cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Current research continues to unravel the molecular background of carcinogenesis and cancer progress. In particular, advances in molecular biology technologies contribute to better tumor profiling, thus paving the way for the investigation of novel, specific, prognostic, and predictive tumor biomarkers. These advances promote the development of new, personalized, and effective therapies, greatly contributing to improved patient outcomes in an era of precise medicine.
This Special Issue aims to present cutting-edge research focusing on the investigation of the molecular mechanisms involved in tumor evolution and progress, as well as exploring potential diagnostic, prognostic, or predictive biomarkers, working towards a more personalized molecular-based therapeutic intervention in cancer.
Original research articles and reviews in this field are welcome.
I look forward to receiving your contributions.
Dr. Georgia Levidou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular biology
- carcinogenesis
- cancer
- biomarkers
- prognostic markers
- predictive markers
- precision medicine
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
